Lawrence Bruno, Chairman and CEO of Core Laboratories Inc. /DE/ (NYSE: CLB), filed a Form 4 on August 4, 2026, disclosing a purchase of 5,000 shares of Common Stock on July 31, 2026.

Key Highlights

  • Reporting person: Lawrence Bruno, serving as Chairman and CEO of Core Laboratories Inc. /DE/
  • Transaction date: July 31, 2026
  • Transaction type: Purchase (transaction code P) of 5,000 shares of Common Stock
  • Purchase price: $10.78 per share
  • Beneficial ownership following transaction: 262,438 shares held directly
  • No derivative securities were reported in Table II of the filing

Bruno's Open-Market Purchase of Core Laboratories Common Stock

According to the filing, Lawrence Bruno, who holds the titles of Director and Chairman and CEO at Core Laboratories Inc. /DE/, acquired 5,000 shares of the company's Common Stock on July 31, 2026. The transaction was recorded under code "P," indicating an open-market purchase. The reported price per share was $10.78. The filing was signed by Mark Tattoli as Attorney-in-Fact on August 4, 2026.

Following this transaction, the filing states that Bruno directly held 262,438 shares of Core Laboratories Common Stock. No indirect ownership or derivative security positions were reported in connection with this filing. Table II of the Form 4, covering derivative securities such as options or warrants, contained no entries.

What Was Disclosed

The filing disclosed a single open-market purchase of 5,000 shares of Core Laboratories Common Stock by Chairman and CEO Lawrence Bruno on July 31, 2026, at $10.78 per share, bringing his direct beneficial ownership to 262,438 shares.